See the Complete Picture.
Published loading...Updated

First Personalized Gene Therapy Using Base Editing Shows Promising Results in Baby with Rare Disorder

  • Researchers reported that KJ Muldoon, a baby from Pennsylvania, is thriving after receiving a personalized gene editing therapy in 2025.
  • KJ was identified soon after birth as having a severe form of CPS1 deficiency, a rare genetic disorder that proves fatal for half of affected infants if left untreated.
  • A specialized team from a leading pediatric research center and a major academic medical institution developed a tailored CRISPR-based treatment, delivered through lipid nanoparticles, to fix his defective gene.
  • KJ received initial and follow-up doses between February and April, with noted improvements in eating and recovering from illnesses; his mother called every milestone "a big moment for us."
  • Experts say this case marks a first step toward broader gene editing treatments for rare diseases, though similar personalized therapies may take years to become widely available.
Insights by Ground AI
Does this summary seem wrong?
Podcasts & Opinions

255 Articles

All
Left
47
Center
110
Right
23
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 61% of the sources are Center
61% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Nature broke the news in United Kingdom on Thursday, May 15, 2025.
Sources are mostly out of (0)